CRNX   $35.57  -0.70% Market Closed After Close 35.57 0.0

Crinetics Pharmaceuticals, Inc.
Total Cash 862.95M
totalCashPerShare 10.782
EBITDA -276.18M
Total Debt 53.32M
quickRatio 15.961
currentRatio 16.087
Total Revenue 1.39M
debtToEquity 6.418
Revenue/Share 0.02
ROA -0.28274
ROE -0.47662
grossProfits
freeCashflow -99.73M
operatingCashflow -178.33M
earningsGrowth
revenueGrowth -0.596
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -207.4762
profitMargins 0.0
enterpriseValue 3.82B
forwardPE -15.326426
floatShares 78.90M
sharesOutstanding 90.04M
sharesShort 6.59M
sharesShortPriorMonth 6.11M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.98%
Short Ratio help_outline 7.40%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 10.473
Price To Book help_outline 5.65
earningsQuarterlyGrowth
netIncomeToCommon -258.54M
trailingEps -3.76%
forwardEps -3.86%
enterpriseToEbitda -13.82
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.91 3Q 2024
institutionsCount 335
lastUpdated Nov. 7, 2024, 2:53 a.m.